TITLE:
Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

CONDITION:
Amphetamine-Related Disorders

INTERVENTION:
Aripiprazole

SUMMARY:

      The purpose of this study is to assess the interactions between intravenous methamphetamine
      and aripiprazole.
    

DETAILED DESCRIPTION:

      This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to
      assess potential interactions between intravenous d-methamphetamine infusion and treatment
      with oral aripiprazole.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 45 Years
Criteria:

        Inclusion Criteria:

          -  Must meet DSM-4 criteria for methamphetamine abuse or dependence and are
             non-treatment seeking.

          -  Ability to verbalize understanding of the consent form, able to provide written
             informed consent, and verbalize willingness to complete study procedures.

        Exclusion Criteria:

          -  Please contact the site for more information.
      
